icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research

Autoimmune Disease Diagnostics Market Set to Attain $10,012.9 Million Valuation by 2030

Oct 15, 2020

According to a report by P&S Intelligence, the global autoimmune disease diagnostics market is projected to generate a revenue of $10,012.9 million by 2030, and is predicted to progress at an 8.5% CAGR during the time period 2020–2030. The market is being driven by the increasing geriatric population, rising incidence of autoimmune diseases, growing initiatives taken by various government and private organizations for raising awareness regarding autoimmune diseases, discovery of biomarkers, and surging strategic developments among major players.

Request to view sample of this market research:

On the basis of application, the autoimmune disease diagnostic market is divided into multiple sclerosis, rheumatoid arthritis (RA), systemic lupus erythematous, scleroderma, Sjogren’s syndrome, sarcoidosis, myasthenia gravis, and others. Out of all these, the RA division is projected to register the highest CAGR in the near future, which can be attributed to the rising awareness programs that are being organized by public and private organizations, growing cases of RA, and discovery of new biomarkers for the diagnosis of this diseases.

The objective of this research includes;

  • Major factors driving the autoimmune disease diagnostic market and their impact during the short, medium, and long terms
  • Market restraints and their impact during the short, medium, and long terms
  • Recent trends and evolving opportunities for the market participants
  • Historical and the present size of the autoimmune disease diagnostic market segments and understand their comparative future potential
  • Potential of on-demand logistics services, so the market players make informed decisions on the sales of their offerings
  • Competitive scenario of various market segments across key countries in several regions for uncovering market opportunities for the stakeholders
  • Major players operating in the autoimmune disease diagnostic market and their service offerings

Geographically, North America is predicted to advance at the fastest pace in the coming years in the autoimmune disease diagnostics market. This can be owing to the widespread burden of autoimmune diseases, enhanced healthcare infrastructure, presence of established players, growing geriatric population, and rising research activities.

Pre-Purchase Inquiry at:

The major players operating in the autoimmune disease diagnostics market are Abbott Laboratories, Thermo Fisher Scientific Inc., bioMérieux S.A., Danaher Corporation, Siemens AG, Seramun Diagnostica GmbH, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Trinity Biotech plc, Exagen Inc., Cambridge Life Sciences Limited, , HYCOR Biomedical, Grifols S.A., ELITech Group, PerkinElmer Inc., Inova Diagnostics, Adaltis S.r.l., ORGENTEC Diagnostika GmbH, Bio-Rad Laboratories Inc., Sigma Diagnostics Inc., and A. Menarini Diagnostics S.r.l.

The research includes detailed analysis of;

Based on Product

  • Consumables and Assay Kits
    • Enzyme-linked immunosorbent assay (ELISA)
    • Antinuclear antibody (ANA) immunofluorescence assay (IFA)
    • Rheumatoid factor (RF) and anti-cyclic citrullinated peptide (CCP) antibody
  • Instruments
    • Automated
    • Semi-automated

Based on Test Type

  • Routine Laboratory
  • Inflammatory Marker
  • Autoantibodies and Immunology
  • Human Leukocyte Antigen (HLA)
  • Cytokine
  • Flow Cytometry

Based on Application

  • Rheumatoid Arthritis (RA)
  • Multiple Sclerosis
  • Systemic Lupus Erythematosus (SLE)
  • Sjögren’s Syndrome
  • Scleroderma
  • Myasthenia Gravis
  • Sarcoidosis

Based on End User

  • Hospitals
  • Diagnosing Centers
  • Academic Institutes and Research Centers

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.


P&S Intelligence

International: +1-347-960-6455




See Campaign:
Contact Information:

Research, Reportedtimes, iCN Internal Distribution, Extended Distribution, Research Newswire, English